JCM Track the topics, authors and articles important to you
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01109-06v1
45/3/1042    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lengerova, M.
Right arrow Articles by Mayer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lengerova, M.
Right arrow Articles by Mayer, J.
Journal of Clinical Microbiology, March 2007, p. 1042-1044, Vol. 45, No. 3
0095-1137/07/$08.00+0     doi:10.1128/JCM.01109-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Real-Time PCR Diagnostics Failure Caused by Nucleotide Variability within Exon 4 of the Human Cytomegalovirus Major Immediate-Early Gene{triangledown}

Martina Lengerova,1* Zdenek Racil,2 Pavlina Volfova,1 Jana Lochmanova,1 Jitka Berkovcova,1 Dana Dvorakova,1 Jiri Vorlicek,2 and Jiri Mayer2

Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematooncology, University Hospital Brno, Brno, Czech Republic,1 Department of Internal Medicine-Hematooncology, University Hospital Brno, Brno, Czech Republic2

Received 30 May 2006/ Returned for modification 17 July 2006/ Accepted 4 January 2007

Here we report how variability in the human cytomegalovirus genome sequence may seriously affect the outcome of its molecular diagnosis. A real-time quantitative PCR assay targeting the major immediate-early gene failed to detect the viral load in some, but not all, clinical samples from hematooncological patients. By amplification and sequencing the DNA across the regions targeted by this assay we found a number of nucleotide substitutions which accounted for decreased primer/probe binding. This decreased the sensitivity of the assay up to 1,000-fold.


* Corresponding author. Mailing address: Center of Molecular Biology and Gene Therapy, University Hospital, Cernopolni 9, CZ-613 00 Brno, Czech Republic. Phone and fax: 420-532 234 623. E-mail: mlengerova{at}fnbrno.cz.

{triangledown} Published ahead of print on 17 January 2007.


Journal of Clinical Microbiology, March 2007, p. 1042-1044, Vol. 45, No. 3
0095-1137/07/$08.00+0     doi:10.1128/JCM.01109-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.